A prospective study of infliximab withdrawal after 12 months of treatment in patients with Crohn's disease: how will NICE guidance affect patient care?
Laura Blackmore and Adam Harris
DOI: https://doi.org/10.7861/clinmedicine.12-3-235
Clin Med June 2012 Laura Blackmore
Department of Gastroenterology, The Tunbridge Wells Hospital
Roles: Specialist registrar in gastroenterology
Adam Harris
Department of Gastroenterology, The Tunbridge Wells Hospital
Roles: Consultant gastroenterologist
Article Tools
Infliximab withdrawal after 12 months as treatment for Crohn's disease
Laura Blackmore, Adam Harris
Clinical Medicine Jun 2012, 12 (3) 235-238; DOI: 10.7861/clinmedicine.12-3-235
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.